Latest Breaking News On - Company group chairman - Page 12 : comparemela.com

(0) CAMBRIDGE, Mass., April 15, 2021 (GLOBE NEWSWIRE) Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced the appointments of Luca Scavo as Chief Financial Officer (CFO), effective June 1, 2021, and Julie H. McHugh to its Board of Directors, effective immediately. Mr. Scavo brings more than 25 years of international experience in both emerging and developed markets within pioneering biotechnology and diagnostics companies including Genentech, Roche and AstraZeneca, where he led teams across diverse global markets and through different stages of a company s life cycle. He most recently served as Senior Vice President and CFO of Roche Diagnostics North America.

United kingdomNew jerseyUnited statesEvelo biosciencesJessica cotroneJulieh mchughRoche latin americaKostenloser wertpapierhandelUniversita politecnica delle marcheLuca scavoEvelo biosciences incBoards of xellia pharmaceuticalsBoard of directors at ironwood pharmaceuticalsPennsylvania state universityEndo health solutionsJoseph university